1Y Close · As of Aug 26, 2026
GENORAY manufactures medical and precision instruments. Medical & Precision
Legal name: GENORAY Co., LTD.
In fiscal year 2025, GENORAY (122310) reported revenue of 108.0 billion KRW, up 1.0% from 107.0 billion KRW a year earlier.
Operating profit was -243 million KRW and net income was 628 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 49.2 billion KRW, with a P/B of 0.59.
These figures can be verified in the DART filing (receipt no. 20260327001840).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 108.0B | -243M | 628M |
| 2024 | 107.0B | 6.5B | -2.5B |
| 2023 | 97.9B | 12.8B | 12.4B |
Checks
No items require attention at this time.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-12 | Corporate Briefing (IR) |